Medical Technology, USACase study
Saving lives with accessible breast screening
2 million+ breast exams, 12 countries, 1 application. See how iBreastExam enables breast cancer detection to be quick, painless and accessible like never before.
We partner with ambitious businesses to unlock 3× revenue growth using deep market insight and build cutting-edge technology. Our compensation is tied directly to your top-line growth—because true partners share outcomes, not invoices.






Our team brings together two worlds that rarely meet at this depth. On one side, we have technologists with hands-on expertise in AI, blockchain, legacy-to-modern tech migrations, and large-scale automation—engineers who build systems designed to scale, not just ship. On the other, we have industry leaders who have built national and global businesses, guided companies from startup to IPO, and navigated every stage of growth in between. This combination allows our clients to see their business through a fundamentally new lens—reframing strategy, identifying non-obvious opportunities, and pursuing growth with conviction. From blue-ocean strategy and M&A to strategic partnerships and inorganic customer acquisition, we operate as a tech company that truly understands business—and aligns every decision toward mutual growth.

Medical Technology, USACase study
Saving lives with accessible breast screening
2 million+ breast exams, 12 countries, 1 application. See how iBreastExam enables breast cancer detection to be quick, painless and accessible like never before.
…we’ve been passionate about building apps with everyone from startups to large corporations that are positively impacting millions of users around the world. Here are some of our accolades.
Creo has been our technology partner since 2010. Providing design, development and strategy across web and native mobile platforms. Varun and his team are thoroughly professional and easy to work with. We are particularly impressed with their technical competence, willingness to help, and flexibility.